imatinib

Imatinib (Piperidine)-N,N-DiOxide Imatinib (Piperidine)-N,N-DiOxide :

Imatinib (Piperidine)-N,N-DiOxide ; CAS : 571186-93-1 ; C29H31N7O3 ; MW: 525.60 ;
Imatinib (Piperidine)-N4-Oxide Imatinib (Piperidine)-N4-Oxide :

Imatinib (Piperidine)-N4-Oxide ; CAS : 938082-57-6 ; C29H31N7O2 ; MW: 509.60 ;
Imatinib (Pyridine)-N-Oxide Imatinib (Pyridine)-N-Oxide:

Imatinib (Pyridine)-N-Oxide ; CAS : 571186-92-0 ; C29H31N7O2 ; MW: 509.60 ;
Imatinib bis Impurity Imatinib bis Impurity:

Imatinib bis Impurity ; 1,4-bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2- yl]amino]phenyl] carbamoyl] benzyl piperazine ; CAS : 1365802-18-1 ; C52H48N12O2 ; MW: 873.02 ;
Imatinib Carboxylic Impurity matinib Carboxylic Impurity:

4-((4-Methylpiperazin-1-yl)methyl)benzoic acid dihydrochloride ; CAS : 106261-49-8 ;C13H20Cl2N2O2 ;  MW: 307.22 ;
Imatinib Diamine N1-Formyl Impurity Imatinib Diamine N1-Formyl Impurity :

6-Methyl-N1-formyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene -1,3-diamine ; C17H15N5O ; MW: 305.33 ;
Imatinib Diamine N1-Formyl N3-Methyl Impurity Imatinib Diamine N1-Formyl N3-Methyl Impurity:

6-Methyl-N1-formyl-N3-methyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine ; C18H17N5O ; MW: 319.36
Imatinib DiPiperidine Impurity Imatinib DiPiperidine Impurity:

N-(4-Methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino) phenyl) -4-((4-(4-((4-methylpiperazin-1-yl)methyl)benzoyl) piperazin-1-yl) methyl)benzamide ; C41H45N9O2 ; MW: 695.86 ;
Imatinib Impurity A Imatinib  Impurity A:

Imatinib Dimethylamino Impurity ; (2E)-3-(Dimethylamino)-1-(pyridin-3-yl)-2-propen-1-one ; CAS : 55314-16-4 ; 10H12N2O ; MW: 176.22 ;
Imatinib Impurity B Imatinib  Impurity B:

Imatinib Guanidino Impurity ; N-(3-Guanidino-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide ; CAS : 581076-65-5 ; C21H28N6O ;

MW: 380.49 ;
Imatinib Impurity C Imatinib Impurity C :

Imatinib N-Desmethyl Impurity ; N-(4-Methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino) phenyl)-4- (piperazin-1-ylmethyl)benzamide ; CAS : 404844-02-6 ; C28H29N7O ;

MW: 479.58 ;
Imatinib Impurity D Imatinib  Impurity D:

Imatinib Dimer ; 1-Methyl-1,4-bis[4-[(4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino] phenyl)carbamoyl]benzyl]piperazin-1-ium chloride ;

C53H51ClN12O2 ; Mol. Wt.: 923.50 ;
Imatinib Impurity F Imatinib  Impurity F:

Imatinib Diamine Impurity ; 6-Methyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene -1,3-diamine ; CAS : 152460-10-1 ;  C16H15N5 ; MW: 277.32 ;
Imatinib Impurity G Imatinib  Impurity G:

1-Methylpiperazine dihydrochloride ; CAS : 109-01-3 (base) ; 34352-59-5 (2 HCl salt) ; C5H14Cl2N2 ; Mol. Wt.: 173.08 ;
Imatinib Impurity H Imatinib  Impurity H:

1-(Pyridin-3-yl)ethanone ; 3-Acetylpyridine ; CAS : 350-03-8 ;

C7H7NO ; Mol. Wt.: 121.14 ;
Imatinib Impurity I Imatinib Impurity I:

N-Methylmethanamine HCl ; Dimethylamine HCl ; CAS : 506-59-2 ;

C2H8ClN ; Mol. Wt.: 81.54 ;
Imatinib Impurity J Imatinib  Impurity J:

Imatinib (Piperidine)-N1-Oxide ; CAS ” 571186-91-9 ; C29H31N7O2 ; MW: 509.60 ;
Imatinib Imidazole Impurity Imatinib Imidazole Impurity :

4-((4-(1H-Imidazole-1-carbonyl)piperazin-1-yl)methyl)-N- (4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)benzamide ; C32H31N9O2 ; MW: 573.65 ;
Imatinib Mesylate Imatinib Mesylate:

CAS : 220127-57-1 (Mesylate) ; C30H35N7O4S ;  MW: 589.71 ;